[HTML][HTML] Platelets, thrombocytosis, and ovarian cancer prognosis: surveying the landscape of the literature

DH Hufnagel, GD Cozzi, MA Crispens… - International Journal of …, 2020 - mdpi.com
Platelets are critical components of a number of physiologic processes, including tissue
remodeling after injury, wound healing, and maintenance of vascular integrity. Increasing …

[HTML][HTML] Pre-treatment thrombocytosis and ovarian cancer survival: A meta-analysis

V Pergialiotis, LV Vokotopoulou, DE Vlachos… - European Journal of …, 2024 - Elsevier
An association between thrombocytosis and cancer progression and decreased survival has
been observed for various forms of cancer. The aim of this study was to evaluate the impact …

Prognostic performance of pretreatment systemic immune-inflammation index in women with epithelial ovarian cancer

KS Okunade, SO John-Olabode, AP Soibi-Harry… - Future Science …, 2023 - Taylor & Francis
Purpose: This study investigated the prognostic performance of the systemic immune-
inflammation index (SII) in patients with epithelial ovarian cancer (EOC) in Lagos, Nigeria …

Predictors of survival outcomes after primary treatment of epithelial ovarian cancer in Lagos, Nigeria

KS Okunade, AA Adejimi, EO Ohazurike… - JCO Global …, 2021 - ascopubs.org
PURPOSE This study was designed to investigate the clinicopathologic predictors of
progression-free survival (PFS) and overall survival (OS) in patients with epithelial ovarian …

Predictors of early mortality risk in patients with epithelial ovarian cancer

KS Okunade, S John‐Olabode… - Health science …, 2022 - Wiley Online Library
Background To improve the overall survival of epithelial ovarian cancer (EOC) patients, a
more precise risk identification after completion of standard treatment will enhance patients' …

[HTML][HTML] Timing of recurrence and overall survival in epithelial ovarian cancer: a 10-year retrospective review

KS Okunade, A Soibi-Harry, T Onyeka… - Hellenic Journal of …, 2022 - hjog.org
Background: The timing of recurrence of epithelial ovarian cancer (EOC) after a standard
primary treatment is an important indicator of the degree of response of the tumour to …

[HTML][HTML] Тромбоцитоз как прогностический фактор у пациентов с первичной медиастинальной В-крупноклеточной лимфомой

ИА Камаева, ИБ Лысенко, НВ Николаева… - Современные …, 2021 - cyberleninka.ru
Введение. Тромбоцитоз–повышение количества тромбоцитов, которое чаще носит
реактивный характер, характеризуется увеличением количества тромбоцитов в …

[PDF][PDF] Timing of recurrence and overall survival in epithelial ovarian cancer: A 10-year retrospective

KS Okunade, A Soibi-Harry, T Onyeka, JB Ogunyemi… - academia.edu
Background: The timing of recurrence of epithelial ovarian cancer (EOC) after a standard
primary treatment is an important indicator of the degree of response of the tumour to …

СОВРЕМЕННЫЕ ПРОБЛЕМЫ ЗДРАВООХРАНЕНИЯ И МЕДИЦИНСКОЙ СТАТИСТИКИ

АА ЯКОВЛЕВ - СОВРЕМЕННЫЕ ПРОБЛЕМЫ ЗДРАВООХРАНЕНИЯ … - elibrary.ru
Актуальность. Сердечная недостаточность является наиболее распространенной
сердечно-сосудистой причиной госпитализации людей старше 60 лет. Она является …

[引用][C] 副肿瘤性血小板增多症相关机制对卵巢癌治疗的影响

张杰, 朱熠, 张国楠 - 肿瘤预防与治疗